EPENDYMOMA RECURRENT
Clinical trials for EPENDYMOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA RECURRENT trials appear
Sign up with your email to follow new studies for EPENDYMOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis study is testing a combination of two drugs—a targeted radioactive drug (177Lu-DOTATATE) and a PARP inhibitor (olaparib)—in children and teens aged 3 to 18 with certain solid tumors that have come back or not responded to treatment. The goal is to see if the combination is s…
Matched conditions: EPENDYMOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kids with tough brain tumors: gene therapy meets immunotherapy and radiation
Disease control Recruiting nowThis early-phase trial is testing a combination of three treatments for children whose brain tumors have come back or not responded to standard care. The experimental drug SGT-53 delivers a normal TP53 gene to tumor cells, and is given alongside the immunotherapy Nivolumab and ra…
Matched conditions: EPENDYMOMA RECURRENT
Phase: EARLY_PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Promising combo therapy offers hope for kids with hard-to-treat brain cancers
Disease control Recruiting nowThis study tests a combination of drugs given in low, frequent doses to slow or stop the growth of recurrent brain tumors in children. The goal is to extend survival while maintaining quality of life. About 232 children with medulloblastoma, ependymoma, ATRT, or other rare CNS tu…
Matched conditions: EPENDYMOMA RECURRENT
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC